The report covers forecast and analysis for the multiplex biomarker imaging market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the multiplex biomarker imaging market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the multiplex biomarker imaging market on a global as well as regional level.
In order to give the users of this report a comprehensive view of the multiplex biomarker imaging market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein application, imaging techniques, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis.
The study provides a decisive view of the multiplex biomarker imaging market by segmenting the market based on application, imaging techniques, end-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024.
Global multiplex biomarker imaging market is divided into its application, imaging techniques, and end-user. On the basis of the application, the market is divided into drug safety, oncology studies, and genetic characterization studies.
Based on imaging techniques multiplex biomarker imaging market is categorized into immunofluorescence (IF) assay, tissue microarray (TMA) assay, immunohistochemistry (IHC) assay, fluorescent in the situ hybridization (FISH) assay, and toponome imaging system (TIS).
On the basis of the end user, the multiplex biomarker imaging market is segregated as research institutes government & private, clinical labs, and pharmaceutical & biotechnology.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for multiplex biomarker imaging based on individual segment and application in all the regions and countries.
The report also includes detailed profiles of end players such as Thermo Fisher Scientific, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abcam Plc., US Biomax Inc., Merck KGaA, ToposNomos Ltd., MicroConstants, Inc., Aushon BioSystems Ltd., Ventana Medical Systems, Inc., Leica Biosystems Nussloch GmbH, Illumina Inc., and others.
This report segments the global multiplex biomarker imaging market as follows:
Global Multiplex Biomarker Imaging Market: By Application
Genetic Characterization Studies
Global Multiplex Biomarker Imaging Market: By Imaging Techniques
Immuno Fluorescence (IF) Assay
Tissue Microarray (TMA) Assay
Immunohistochemistry (IHC) Assay
Fluorescent in the Situ Hybridization (FISH) Assay
Toponome Imaging System (TIS)
Global Multiplex Biomarker Imaging Market: By End User
Research Institutes Government & Private
Pharmaceutical & Biotechnology
Global Multiplex Biomarker Imaging Market: By Region
The Middle East and Africa